Virex Pharma Ltd is pleased to announce it is a finalist in the Western Australia Innovator of the Year (WA IOTY) Awards in two categories of Rio Tinto Emerging Innovation category and Wesfarmers Wellbeing Platinum Award Finalists.
The WA IOTY Program is an initiative administered by Department of Jobs, Tourism, Science and Innovation and showcases the State’s brightest innovators and entrepreneurs, helping them realise the full potential of their product or idea. Winners for this year will be announced at an awards ceremony on 21 November 2023.
The awards are sponsored by Rio Tinto, Business News, Wesfarmers, Woodside Energy, Griffith Hack, Nexia Australia, Wrays, CERI, Biodesign Australia, Murfett Legal, Moore Australia and PwC.
For media inquiries or further information, please contact:
[Ms Rolee Kumar roleek@virexpharma.com]
About Virex Pharma:
Virex Pharma Ltd (www.virexpharma.com.au) is an innovative biopharmaceutical company dedicated to developing antiviral therapies for infections caused by RSV, COVID-19 and Dengue viruses. With a focus on addressing critical unmet medical needs, Virex’s research and development efforts aim to revolutionise the treatment landscape for viral infections. Through cutting-edge science, rigorous clinical investigations, and strategic partnerships, Virex strives to bring breakthrough therapies to patients worldwide.
